Pictet Asset Management Sa Reata Pharmaceuticals Inc Transaction History

Pictet Asset Management Sa

$83.4 Billion
Q2 2023

A detailed history of Pictet Asset Management Sa transactions in Reata Pharmaceuticals Inc stock. As of the latest transaction made, Pictet Asset Management Sa holds 2,646 shares of RETA stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,646

Previous 3,204 17.42%

Holding current value

Previous $291,000 7.56%

% of portfolio

0.0%

Previous 0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$79.22 - $105.37 $44,204 - $58,796	-558 Reduced 17.42%	2,646 $269,000
Q1 2023 May 10, 2023	BUY	$30.85 - $93.17 $98,843 - $298,516	3,204 New	3,204 $291,000
Q4 2021 Feb 10, 2022	SELL	$25.61 - $110.96 $2.53 Million - $10.9 Million	-98,616 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$100.0 - $143.02 $9.86 Million - $14.1 Million	98,616 New	98,616 $9.92 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.

Account

Pictet Asset Management Sa Reata Pharmaceuticals Inc Transaction History